Search - tctmd.com

Displaying 81 - 100 of 502

Sort: Relevancy | Date

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

L.A. McKeown

June 18, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Conference News ACC 2021

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Yael L. Maxwell

May 17, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

Primary PCI After TAVI: New Real-world Insights

Caitlin E. Cox

April 27, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Todd Neale

April 16, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Caitlin E. Cox

April 12, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

Advertisement

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

OMT Boosts Survival in Revascularized Patients at 10 Years

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

May 2021 News Roundup

Primary PCI After TAVI: New Real-world Insights

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Observational Study Supports Continuing Oral Anticoagulation During PCI

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content